NYSE:CAH - Cardinal Health Stock Price, Price Target & More

Cardinal Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "CAH."

Cardinal Health declared a quarterly dividend on Wednesday, May 9th. Investors of record on Monday, July 2nd will be given a dividend of $0.476 per share on Sunday, July 15th. This represents a $1.90 annualized dividend and a yield of 3.75%. The ex-dividend date of this dividend is Friday, June 29th. This is a boost from Cardinal Health's previous quarterly dividend of $0.46. View Cardinal Health's Dividend History.

Cardinal Health declared that its Board of Directors has approved a share buyback program on Thursday, February 8th 2018, which permits the company to buyback $1,000,000,000.00 in outstanding shares, according to EventVestor. This buyback authorization permits the company to repurchase shares of its stock through open market purchases. Shares buyback programs are generally an indication that the company's board believes its shares are undervalued.

Cardinal Health Inc (NYSE:CAH) posted its quarterly earnings results on Thursday, May, 3rd. The company reported $1.39 EPS for the quarter, missing the Zacks' consensus estimate of $1.51 by $0.12. The firm had revenue of $33.63 billion for the quarter, compared to the consensus estimate of $33.61 billion. Cardinal Health had a return on equity of 23.39% and a net margin of 1.26%. View Cardinal Health's Earnings History.

Cardinal Health is scheduled to release their next quarterly earnings announcement on Tuesday, July, 31st 2018. View Earnings Estimates for Cardinal Health.

Cardinal Health updated its FY18 earnings guidance on Thursday, May, 3rd. The company provided earnings per share guidance of $4.85-4.95 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $5.42.

15 equities research analysts have issued 1 year price targets for Cardinal Health's stock. Their predictions range from $40.00 to $81.00. On average, they anticipate Cardinal Health's share price to reach $66.9286 in the next twelve months. This suggests a possible upside of 32.0% from the stock's current price. View Analyst Ratings for Cardinal Health.

15 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cardinal Health in the last year. There are currently 2 sell ratings, 9 hold ratings and 4 buy ratings for the stock, resulting in a consensus recommendation of "Hold."

Some companies that are related to Cardinal Health include McKesson (MCK), AmerisourceBergen (ABC), Herbalife Nutrition (HLF), Nu Skin Enterprises (NUS), PetIQ (PETQ), Aceto (ACET), biOasis Technologies (BIOAF), Trxade Group (TRXD) and Medizone International (MZEI).

News headlines about CAH stock have been trending positive on Tuesday, according to Accern Sentiment Analysis. Accern ranks the sentiment of press coverage by reviewing more than twenty million blog and news sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Cardinal Health earned a daily sentiment score of 0.28 on Accern's scale. They also assigned news coverage about the company an impact score of 45.15 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the company's share price in the next several days.

Cardinal Health's stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include Hexavest Inc. (0.30%), Bank of Montreal Can (0.09%), Howard Capital Management Inc. (0.07%), Denali Advisors LLC (0.04%), Kempner Capital Management Inc. (0.03%) and Fjarde AP Fonden Fourth Swedish National Pension Fund (0.03%). Company insiders that own Cardinal Health stock include Craig S Morford, Donald M Jr Casey, George S Barrett, Jon L Giacomin, Michael C Kaufmann, Patricia Morrison and Stuart G Laws. View Institutional Ownership Trends for Cardinal Health.

CAH stock was sold by a variety of institutional investors in the last quarter, including Bank of Montreal Can, Hexavest Inc., Riverbridge Partners LLC, Trust Co. of Toledo NA OH, Welch & Forbes LLC and Gateway Investment Advisers LLC. Company insiders that have sold Cardinal Health company stock in the last year include Jon L Giacomin, Michael C Kaufmann and Patricia Morrison. View Insider Buying and Selling for Cardinal Health.

CAH stock was acquired by a variety of institutional investors in the last quarter, including Capital Investment Advisors LLC, Howard Capital Management Inc., State of Alaska Department of Revenue, Regent Investment Management LLC, Kempner Capital Management Inc., Denali Advisors LLC, DnB Asset Management AS and Cito Capital Group LLC. View Insider Buying and Selling for Cardinal Health.

Shares of CAH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of CAH stock can currently be purchased for approximately $50.71.

Cardinal Health has a market capitalization of $15.78 billion and generates $129.98 billion in revenue each year. The company earns $1.29 billion in net income (profit) each year or $5.40 on an earnings per share basis. Cardinal Health employs 28,000 workers across the globe.

Cardinal Health's mailing address is 7000 CARDINAL PLACE, DUBLIN OH, 43017. The company can be reached via phone at 614-757-5000 or via email at [email protected]